©The Author(s) 2025.
World J Gastrointest Endosc. Sep 16, 2025; 17(9): 108787
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.108787
Published online Sep 16, 2025. doi: 10.4253/wjge.v17.i9.108787
Table 2 Results of radiofrequency ablation for the treatment of gastric antral vascular ectasia
| Ref. | Total number of patients /with LC | Other gastric mucosa lesions | Number of RFA sessions | Follow-up (month) | Efficacy | Recurrence, treatment failure, post-treatment blood transfusions, adverse events, complications |
| Gross et al[60] | 6/N/A | One patient (16.7%) had superficial gastric ulcer | 1.7 (range 1-3) | N/A | There was a significant increase in hemoglobin levels | One patient (16.7%) remained dependent on blood transfusions, but the overall need for blood transfusion decreased |
| McGorisk et al[61] | 21/18 | Two patients (9.5%) had EV, five patients (23.8%) had PHG | 1.9 ± 0.6 (range 1-3) | 6 | Technical and clinical successes were 90% and 86%, respectively | Three patients (14.3%) required post-treatment blood transfusions; one patient (4.8%) had superficial gastric ulceration, one patient (4.8%) had ulcer bleeding and one patient (4.8%) continued to have GAVE associated bleeding |
| Dray et al[62] | 24/11 | N/A | 1.8 ± 0.8 (range 1-3) | 6 | There was a significant increase in hemoglobin levels and a decrease in the need for blood transfusion | There were no reports of any perioperative or inpatient postoperative complications |
| Jana et al[63] | 7/2 | N/A | Median 2 (range 1-3) | Median 6 (range 8-15) | Technical and clinical successes were 100% and 71%, respectively | Two patients (29%) required post-treatment blood transfusions; there were no reports of any perioperative or inpatient postoperative complications |
| Raza et al[64] | 9/4 | One LC patient (25%) had PHG | Median 3 (range 2-6) | Median 11 (range 6-21) | Technical success was 100% | Three patients (33.3%) had a recurrence of GAVE, and required blood transfusions and retreatment |
| Dunn et al[65] | 15/3 | N/A | Median 2 | Median 2 (range 1-6) | Clinical and endoscopic responses were 87% and 20%, respectively. There was a significant increase in hemoglobin levels and a decrease in the need for blood transfusion | Four patients (26.7%) required post-treatment blood transfusions |
| Markos et al[66] | 15/0 | N/A | Median 2 (range 1-3) | Median 11 (range 5-18) | Technical and clinical successes were 100% and 80%, respectively. There was a significant increase in hemoglobin levels | Five patients (33.3%) required post-treatment blood transfusions |
| Senzolo et al[67] | 40/40 | N/A | N/A | 6 | There was a significant increase in hemoglobin levels and a decrease in the need for blood transfusion | No major complication occurred and liver function remained stable in all patients |
| Magee et al[68] | 20/4 | N/A | Median 2 (range 1-2) | 6 | There was a significant increase in hemoglobin levels | Three patients (15%) required post-treatment blood transfusions; three patients (15%) experienced epigastric pain which was managed with oral pain medications |
- Citation: Olevskaya ER, Dolgushina AI, Garbuzenko DV, Khikhlova AO, Saenko AA, Khusainova GM, Kuznetsova AS. Role of endoscopy in the diagnosis and treatment of gastric mucosal lesions in liver cirrhosis patients. World J Gastrointest Endosc 2025; 17(9): 108787
- URL: https://www.wjgnet.com/1948-5190/full/v17/i9/108787.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i9.108787